In VivoFinancings Third-quarter 2016 biopharma financing totaled $7.4 billion, a 54% increase over Q2’s $4.8 billion. Follow-on public offerings were again the lead financing vehicle, bringing in $3.36 billi
In VivoIN VITRO DIAGNOSTICS Alliances Cleveland HeartLab LLC Global Discovery Biosciences Global Discovery Biosciences licensed Cleveland HeartLab Inc. exclusive rights to distribute its PULS ( Prote